Available Now

Weight loss, in a once-daily tablet.

The proven GLP-1 science of Wegovy & Mounjaro — without the needle. Be first when it lands in the UK.

Start Consultation

Free · no commitment Unsubscribe anytime
SKJM+ 1,240+ already on the waitlist
Meet the new GLP-1 pill
Meet the new GLP-1 pill
↓32lbs
Once-daily tablet · room-temp storageNo needles · no fridgeUp to ~15–17% in trials
Side by side

GLP-1 tablets vs injections

Two routes to the same active science. Tablets are coming soon; injections are available today — here's how they compare.

Compare
Recommended GLP-1 tablets Oral · once daily
Available now GLP-1 injections Weekly pen
Avg. weight loss
12–17%in clinical trials
17–22%in clinical trials
Format
Once-daily tablet
Weekly injection pen
Storage
Cupboard · room temp
Fridge · 2–8°C
Needles & sharps
None
Disposal needed
Availability
Available Now
Available now
Get started

Figures are clinical trial averages — individual results vary. Weight-loss medicines are prescription-only and require a free consultation reviewed by a UK prescriber.

In the pipeline

The two tablets coming to the UK

Both are once-daily oral GLP-1 medicines in late-stage development. Join the waitlist and we'll tell you the moment either is available.

Oral SemaglutideAvailable Now
Oral Semaglutide · Wegovy Pill
Average weight loss ~15%
FormatOnce-daily tablet
Strengths1.5 mg to 25 mg
StorageRoom temperature
Same family asWegovy
ExpectedNow Available
Start Consultation
Foundayo (Orforglipron)Phase 3 complete · next in line
Foundayo (Orforglipron) · Eli Lilly
Average weight loss ~12%
FormatOnce-daily tablet
TypeSmall-molecule
StorageRoom temperature
Injection neededNo
ExpectedFiling 2026
Coming soon

Trial averages — individual results vary. Joining the waitlist does not guarantee supply or a prescription. Oral GLP-1 medicines are not yet licensed in the UK; availability is subject to MHRA approval.

Updated monthly · UK approval

Next to land: the oral tablet.

Where every GLP-1 medicine we track sits with UK regulators — and which one reaches your door first.

Now Available Live status
Novo Nordisk
Oral Semaglutide

The first oral GLP-1 tablet — the same active family as Wegovy, now with UK regulators.

Trials
Filed
Approved
Available
~17%
Avg. trial weight loss
Daily
One tablet
Eli Lilly Next in line
Orforglipron

A small-molecule oral GLP-1 — no special storage. Phase 3 complete, UK filing expected during 2026.

Trials done · awaiting filing
Notify me when it lands
Mounjaro & Wegovy Available now
Don't want to wait?
In stock

from £89 / month · weekly injection

Explore injections available now
Updated by our pharmacy team · Next update: 1 July 2026 Sources: MHRA registers & manufacturer disclosures · estimates may change

Get first access to oral GLP-1 treatment

Waitlist members get the earliest route to tablets — and the best terms when they launch.

Start Consultation

One daily pill.
No needles,
no fridge.

The oral GLP-1 tablet, now available to order in the UK.

Fast, prescriber-led consultations

Complete a short online assessment and our clinical team reviews whether the pill is right for you — usually within hours.

Launch pricing

£30 off your first order with code FIRST30, and £25 off repeat orders with DOSE25.

Simple from start to finish

Complete a short online assessment and let our clinical team handle the rest — no appointments, no queues.

Safety & regulation

A real UK pharmacy, on the record

GPhC-registered pharmacy

EveryDayMeds is operated by OVIO Ltd and registered with the General Pharmaceutical Council: 9012878.

Check the GPhC register
Only genuine, MHRA-licensed medicines — dispensed against a prescription.
Prescription-only treatment, reviewed by a UK-registered prescriber.
Free online consultation — no obligation to proceed.
Our independent prescribers
SS
Shelan Salih
Independent Prescriber · GPhC 2084601
RU
Rehenaaz Uddin
Independent Prescriber · GPhC 2083436

Oral GLP-1 is not yet launched in the UK. Joining the waitlist does not create a prescription or guarantee supply. All treatment decisions are made by a prescriber based on your individual suitability.

Questions & answers

Oral GLP-1, answered honestly

It's a once-daily oral form of a GLP-1 weight-loss medicine — the same class of treatment as the well-known injections, but taken as a tablet instead of a weekly jab. It works by helping to regulate appetite and how full you feel.

Yes. Oral GLP-1 treatment is available to order from EverydayMeds today, following a short online consultation and prescriber approval.

Both use the same class of medicine to support weight loss. The main difference is the format: a daily tablet rather than a weekly injection, with no needles, no sharps bin, and no need to refrigerate. Your prescriber can help you decide which is right for you.

Yes. Licensed switching from injectable Wegovy or Mounjaro to the oral tablet is possible, but it should always be guided by a prescriber rather than managed on your own. During your consultation, our clinical team will confirm the right starting dose for you.

Eligibility depends on factors like your BMI, medical history, and current medications. Complete our short online assessment and our prescribers will review whether the treatment is suitable and safe for you.

Yes. Oral GLP-1 is a prescription-only medicine. You'll complete an online consultation, and one of our prescribers will review it before any treatment is issued.

The most common side effects are gastrointestinal — such as nausea, and changes to digestion — particularly when starting or increasing your dose. These often ease over time. Your prescriber will go through what to expect, and you should always read the patient information leaflet.

Your treatment is sent in plain, discreet packaging directly to your door, once your prescriber has approved your order.

Our pharmacists and prescribers are on hand throughout your treatment to answer questions and guide you at every step.

Yes. EverydayMeds is a GPhC-registered pharmacy operating from the UK, and all treatments are prescribed by registered clinicians.